Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  761 results for ""Hypoglycemic Agents""

Your Filters

Geographic : canada
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis.

  • Authors : Ali MU; Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, McMaster University, Hamilton, Canada.; Mancini GBJ

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 15; Vol. 23 (1), pp. 72. Date of Electronic Publication: 2024 Feb 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Open-source Artificial Pancreas Systems Are Safe and Effective When Supported In-clinic: Outcomes in 248 Consecutive Type 1 Diabetes Clients.

  • Authors : Samuel P; BCDiabetes, Vancouver, British Columbia, Canada.; Khan N

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Pancreas, Artificial* ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/prevention & control

  • Source: Canadian journal of diabetes [Can J Diabetes] 2024 Feb; Vol. 48 (1), pp. 59-65.e1. Date of Electronic Publication: 2023 Oct 05.Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Utility of Switching to Insulin Degludec From Other Basal Insulins in Adult Patients With Type 1 or Type 2 Diabetes.

  • Authors : Baran O; Alberta Health Services, Foothills Medical Centre, Calgary, Alberta, Canada. Electronic address: .; Dersch-Mills D

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Canadian journal of diabetes [Can J Diabetes] 2022 Jun; Vol. 46 (4), pp. 381-387.e4. Date of Electronic Publication: 2021 Dec 30.Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Factors associated with early nonpersistence among patients experiencing side effects from a new medication.

Subjects: Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/adverse effects ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/adverse effects; Aged

  • Source: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2022 May-Jun; Vol. 62 (3), pp. 717-726.e5. Date of Electronic Publication: 2021 Dec 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101176252 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.

  • Authors : Tsoukas MA; Division of Endocrinology and Metabolism, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.; Majdpour D

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Insulin Infusion Systems*/Insulin Infusion Systems*/Insulin Infusion Systems*/adverse effects

  • Source: The Lancet. Digital health [Lancet Digit Health] 2021 Nov; Vol. 3 (11), pp. e723-e732. Date of Electronic Publication: 2021 Sep 24.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States.

Subjects: Bridged Bicyclo Compounds, Heterocyclic/Bridged Bicyclo Compounds, Heterocyclic/Bridged Bicyclo Compounds, Heterocyclic/*administration & dosage ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage ; Metformin/Metformin/Metformin/*administration & dosage

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 May; Vol. 10 (5), pp. 510-520. Date of Electronic Publication: 2020 Nov 02.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study.

Subjects: Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/adverse effects ; Glycemic Control*/Glycemic Control*/Glycemic Control*/adverse effects; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects

  • Source: Diabetes & vascular disease research [Diab Vasc Dis Res] 2021 Jul-Aug; Vol. 18 (4), pp. 14791641211021374.Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print Cited Medium: Internet ISSN: 1752-8984

Record details

Read More Add to Saved list
×
Academic Journal

Self-reported Severe and Nonsevere Hypoglycemia in Type 1 Diabetes: Population Surveillance Through the BETTER Patient Engagement Registry: Development and Baseline Characteristics.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/epidemiology ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/chemically induced

  • Source: Canadian journal of diabetes [Can J Diabetes] 2022 Dec; Vol. 46 (8), pp. 813-821. Date of Electronic Publication: 2022 May 28.Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.

Subjects: Disease Management*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Canadian journal of diabetes [Can J Diabetes] 2020 Oct; Vol. 44 (7), pp. 592-596.Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update.

Subjects: Disease Management*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Canadian journal of diabetes [Can J Diabetes] 2020 Oct; Vol. 44 (7), pp. 575-591.Publisher: Canadian Diabetes Association Country of Publication: Canada NLM ID: 101148810 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  761 results for ""Hypoglycemic Agents""